CIK 0001841387
- Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522214851
- Phone
- +1 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,160,783
- in 1 filing, $3.2M under 10b5-1 plans
Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Barone Francesca Chief Scientific Officer | Sale 10b5-1 | −23,447 | $10.06 | $236K | 77,362 |
| 2026-01-26 | Barone Francesca Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +232,000 | 232,000 | ||
| 2025-06-25 | Barone Francesca Chief Scientific Officer | Grant or award | +4,282 | $4.67 | $20K | 100,809 |
| 2025-03-18 | Barone Francesca Chief Scientific Officer | Option exercise 10b5-1 | +18,000 | $1.55 | $28K | 128,673 |
| 2025-03-18 | Barone Francesca Chief Scientific Officer | Sale 10b5-1 | −32,146 | $8.76 | $282K | 96,527 |
| 2025-03-18 | Barone Francesca Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,000 | 30,822 | ||
| 2025-02-12 | Barone Francesca Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2025-01-15 | Barone Francesca Chief Scientific Officer | Sale | −13,534 | $7.23 | $98K | 110,673 |
| 2025-01-08 | Barone Francesca Chief Scientific Officer | Sale | −13,673 | $8.22 | $112K | 124,207 |
| 2024-11-29 | Barone Francesca Chief Scientific Officer | Sale | −22,081 | $4.56 | $101K | 137,880 |
| 2024-07-17 | Barone Francesca Chief Scientific Officer | Sale | −14,051 | $6.47 | $91K | 159,961 |
| 2024-07-11 | Barone Francesca Chief Scientific Officer | Sale | −12,645 | $5.97 | $76K | 174,012 |
| 2023-11-28 | Barone Francesca Chief Scientific Officer | Shares withheld for taxes | −19,748 | $0.90 | $18K | 186,657 |
| 2023-11-26 | Barone Francesca Chief Scientific Officer | Grant or award | +112,790 | 206,405 | ||
| 2023-04-28 | Barone Francesca Chief Scientific Officer | Grant or award · Stock Option (Right to Biuy) | +90,000 | 90,000 | ||
| 2022-12-08 | Barone Francesca Chief Scientific Officer | Purchase | +1,238 | $1.61 | $2K | 2,738 |
| 2022-11-28 | Barone Francesca Chief Scientific Officer | Grant or award | +90,877 | 92,377 | ||
| 2022-02-28 | Barone Francesca Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2022-02-03 | Barone Francesca Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 1 of 1 · 19 trades